You must log in to view this page.

Karyopharm Therapeutics Inc. – Filings and Transcripts

NASDAQ: KPTI
Share price (3/30/26): $5.30
Market cap (3/30/26): $97.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Shelf registration

Shelf registration

Registration of securities for employees

Ownership Filter

Cheng Sohanya Roshan

Rangwala Reshma

News Filter

Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction

Material Definitive Agreement, Other Events, Financial Statements or Exhibits

Shareholder Vote Results

Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission